Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child (Q24193032)

1

0 references

Jennifer Weston

2

0 references

Naghme Adab

3

0 references

Janette Greenhalgh

4

0 references

Anna Sanniti

5

0 references

Andrew J McKay

6

0 references

Anthony G Marson

Cochrane Database of Systematic Reviews

8

0 references

publication date

30 October 2014

0 references

published in

0 references

cites work

Early cognitive development in children born to women with epilepsy: a prospective report.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Autism spectrum disorders following in utero exposure to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Intelligence of children of epileptic mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Normal intelligence in children with prenatal exposure to carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The psychological development of children of epileptic parents. I. Study design and comparative findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Infants exposed in utero to antiepileptic drugs. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Physical and psychomotor development in the offspring born to mothers with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Language skills of school-aged children prenatally exposed to antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Preliminary findings of the developmental effects of in utero exposure to topiramate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Child development following in utero exposure: levetiracetam vs sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Motor and mental development of infants exposed to antiepileptic drugs in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Exposure to antiepileptic drugs in utero and child development: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Do anticonvulsants have a teratogenic effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Teratogenicity of anticonvulsant drugs. II: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Antiepileptic drugs and teratogenicity in Nigerians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Effects of breastfeeding in children of women taking antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

A clinical study of 57 children with fetal anticonvulsant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

In utero exposure to phenobarbital and intelligence deficits in adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Psychomotor development and general movements in offspring of women with epilepsy and anticonvulsant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Characteristics of fetal anticonvulsant syndrome associated autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Psychopathology and mental functions in the offspring of alcoholic and epileptic mothers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Changing trends in antiepileptic drug prescribing in girls of child-bearing potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Additional educational needs in children born to mothers with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Common antiepileptic drugs in pregnancy in women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The longer term outcome of children born to mothers with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Verification of the fetal valproate syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

21 January 2018

The teratology of autism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Antiepileptic drugs and apoptosis in the developing brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

21 January 2018

Fetal valproate syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Intelligence and educational achievement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Comparative safety of antiepileptic drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Antiepileptic drug use in women of childbearing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Patient knowledge about issues related to pregnancy in epilepsy: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Neurologists' and neurology residents' knowledge of issues related to pregnancy for women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010236.PUB2

[Treatment of pregnant epileptics with carbamazepine. Preliminary report]

21 January 2018

1 reference

12 December 2020

Intelligence and physical features of children of women with epilepsy

1 reference

12 December 2020

Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems

1 reference

12 December 2020

Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations.

1 reference

12 December 2020

Health status of children born to mothers with epilepsy

1 reference

12 December 2020

Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome

1 reference

12 December 2020

Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs.

1 reference

12 December 2020

Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.

1 reference

12 December 2020

The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents

1 reference

12 December 2020

[Delayed effects of prenatal exposure to phenobarbital on intelligence--Phenemal]

1 reference

12 December 2020

Psychomotor development in preschool children exposed to antiepileptic drugs in utero.

1 reference

12 December 2020

Fetal phenytoin exposure, hypoplastic nails, and jitteriness

1 reference

12 December 2020

Maternal epilepsy and offsprings' adult intelligence: a population-based study from Norway

1 reference

12 December 2020

Intellectual, psychomotor and speech development of children born to mothers with epilepsy

1 reference

12 December 2020

[Valproate induced fetopathy and somatic and psychomotor development]

1 reference

12 December 2020

Epilepsy in pregnancy: developmental outcome of offspring at 12 months.

1 reference

12 December 2020

A prospective follow-up of the offspring of epileptic patients

1 reference

12 December 2020

Physical growth and psychomotor development of infants exposed to antiepileptic drugs in utero

1 reference

12 December 2020

Specific cognitive dysfunction in children with epileptic mothers

1 reference

12 December 2020

Fetal valproate syndrome: is there a recognisable phenotype?

1 reference

12 December 2020

Antiepileptic drugs in pregnancy: late effects on the children's cognitive abilities. Preliminary data

1 reference

12 December 2020

Intellectual and language functions in children of mothers with epilepsy.

1 reference

12 December 2020

Neuropsychological outcomes in children of mothers with epilepsy

1 reference

12 December 2020

A male with fetal valproate syndrome and autism.

1 reference

12 December 2020

Pregnancy, teratogenesis, and epilepsy.

1 reference

12 December 2020

Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study

1 reference

12 December 2020

Study of children of mothers treated with anticonvulsants during pregnancy

1 reference

12 December 2020

School performance at age 16 in children exposed to antiepileptic drugs in utero—A population‐based study

1 reference

12 December 2020

[Children of epileptic mothers (author's transl)]

1 reference

12 December 2020

Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations

1 reference

12 December 2020